NL179257C - PROCESS FOR PREPARING A MEDICINAL PRODUCT CONTAINING AS 4-PIPERAZINYLPYRIMIDINE DERIVATIVE AS AN ACTIVE COMPOUND AND PROCESS FOR PREPARING ACTIVE COMPOUNDS TO BE USED THEREOF - Google Patents

PROCESS FOR PREPARING A MEDICINAL PRODUCT CONTAINING AS 4-PIPERAZINYLPYRIMIDINE DERIVATIVE AS AN ACTIVE COMPOUND AND PROCESS FOR PREPARING ACTIVE COMPOUNDS TO BE USED THEREOF

Info

Publication number
NL179257C
NL179257C NLAANVRAGE7312321,A NL7312321A NL179257C NL 179257 C NL179257 C NL 179257C NL 7312321 A NL7312321 A NL 7312321A NL 179257 C NL179257 C NL 179257C
Authority
NL
Netherlands
Prior art keywords
preparing
piperazinylpyrimidine
derivative
product containing
medicinal product
Prior art date
Application number
NLAANVRAGE7312321,A
Other languages
Dutch (nl)
Other versions
NL7312321A (en
NL179257B (en
Inventor
Gerard Loiseau
Georges Mattioda
Rene Millischer
Pierre Obellianne
Original Assignee
Ugine Kuhlmann
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7324874A external-priority patent/FR2257294B1/fr
Application filed by Ugine Kuhlmann filed Critical Ugine Kuhlmann
Publication of NL7312321A publication Critical patent/NL7312321A/en
Publication of NL179257B publication Critical patent/NL179257B/en
Application granted granted Critical
Publication of NL179257C publication Critical patent/NL179257C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56—One oxygen atom and one sulfur atom
    • G—PHYSICS
    • G05—CONTROLLING; REGULATING
    • G05F—SYSTEMS FOR REGULATING ELECTRIC OR MAGNETIC VARIABLES
    • G05F1/00—Automatic systems in which deviations of an electric quantity from one or more predetermined values are detected at the output of the system and fed back to a device within the system to restore the detected quantity to its predetermined value or values, i.e. retroactive systems
    • G05F1/10—Regulating voltage or current
    • G05F1/46—Regulating voltage or current wherein the variable actually regulated by the final control device is dc
    • G—PHYSICS
    • G05—CONTROLLING; REGULATING
    • G05F—SYSTEMS FOR REGULATING ELECTRIC OR MAGNETIC VARIABLES
    • G05F3/00—Non-retroactive systems for regulating electric variables by using an uncontrolled element, or an uncontrolled combination of elements, such element or such combination having self-regulating properties
    • G05F3/02—Regulating voltage or current
    • G05F3/08—Regulating voltage or current wherein the variable is dc
    • G05F3/10—Regulating voltage or current wherein the variable is dc using uncontrolled devices with non-linear characteristics
    • G05F3/16—Regulating voltage or current wherein the variable is dc using uncontrolled devices with non-linear characteristics being semiconductor devices
    • G05F3/20—Regulating voltage or current wherein the variable is dc using uncontrolled devices with non-linear characteristics being semiconductor devices using diode- transistor combinations
    • G—PHYSICS
    • G05—CONTROLLING; REGULATING
    • G05F—SYSTEMS FOR REGULATING ELECTRIC OR MAGNETIC VARIABLES
    • G05F3/00—Non-retroactive systems for regulating electric variables by using an uncontrolled element, or an uncontrolled combination of elements, such element or such combination having self-regulating properties
    • G05F3/02—Regulating voltage or current
    • G05F3/08—Regulating voltage or current wherein the variable is dc
    • G05F3/10—Regulating voltage or current wherein the variable is dc using uncontrolled devices with non-linear characteristics
    • G05F3/16—Regulating voltage or current wherein the variable is dc using uncontrolled devices with non-linear characteristics being semiconductor devices
    • G05F3/20—Regulating voltage or current wherein the variable is dc using uncontrolled devices with non-linear characteristics being semiconductor devices using diode- transistor combinations
    • G05F3/22—Regulating voltage or current wherein the variable is dc using uncontrolled devices with non-linear characteristics being semiconductor devices using diode- transistor combinations wherein the transistors are of the bipolar type only
    • G05F3/222—Regulating voltage or current wherein the variable is dc using uncontrolled devices with non-linear characteristics being semiconductor devices using diode- transistor combinations wherein the transistors are of the bipolar type only with compensation for device parameters, e.g. Early effect, gain, manufacturing process, or external variations, e.g. temperature, loading, supply voltage
    • G05F3/227—Regulating voltage or current wherein the variable is dc using uncontrolled devices with non-linear characteristics being semiconductor devices using diode- transistor combinations wherein the transistors are of the bipolar type only with compensation for device parameters, e.g. Early effect, gain, manufacturing process, or external variations, e.g. temperature, loading, supply voltage producing a current or voltage as a predetermined function of the supply voltage

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Microelectronics & Electronic Packaging (AREA)
  • Electromagnetism (AREA)
  • General Physics & Mathematics (AREA)
  • Radar, Positioning & Navigation (AREA)
  • Automation & Control Theory (AREA)
  • Nonlinear Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NLAANVRAGE7312321,A 1953-06-19 1973-09-07 PROCESS FOR PREPARING A MEDICINAL PRODUCT CONTAINING AS 4-PIPERAZINYLPYRIMIDINE DERIVATIVE AS AN ACTIVE COMPOUND AND PROCESS FOR PREPARING ACTIVE COMPOUNDS TO BE USED THEREOF NL179257C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL752031X 1953-06-19
FR7324874A FR2257294B1 (en) 1973-07-06 1973-07-06

Publications (3)

Publication Number Publication Date
NL7312321A NL7312321A (en) 1975-01-08
NL179257B NL179257B (en) 1986-03-17
NL179257C true NL179257C (en) 1986-08-18

Family

ID=26217821

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE7312321,A NL179257C (en) 1953-06-19 1973-09-07 PROCESS FOR PREPARING A MEDICINAL PRODUCT CONTAINING AS 4-PIPERAZINYLPYRIMIDINE DERIVATIVE AS AN ACTIVE COMPOUND AND PROCESS FOR PREPARING ACTIVE COMPOUNDS TO BE USED THEREOF

Country Status (1)

Country Link
NL (1) NL179257C (en)

Also Published As

Publication number Publication date
NL7312321A (en) 1975-01-08
NL179257B (en) 1986-03-17

Similar Documents

Publication Publication Date Title
FR1068M (en) New anticholesteremic product.
FR1240517A (en) Fungicidal product containing 2, 3-dicyano-1, 4-dithia-anthrahydroquinone
NL171957B (en) PROCESS FOR THE PREPARATION OF A PESTICID, CONTAINING AS FURANCARBONIC ACID AMID DERIVATIVE AS AN ACTIVE INGREDIENT
NL163209C (en) PROCESS FOR PREPARING 2-HYDROXY-4-METHYL-THIOBUTYRONITRILE.
NL187239B (en) N-SUBSTITUATED 2-CYANAZIRIDINE DERIVATIVE, METHOD FOR PREPARING IT AND PHARMACEUTICAL PREPARATION CONTAINING SUCH PREPARATION.
NL169755B (en) PROCESS FOR PREPARING A THIOPEPTINE AND A PROCESS FOR PREPARING A FEED OR FEED COMPONENT CONTAINING THIOPEPTINE.
NL98859C (en) PROCESS FOR THE PREPARATION OF THERAPEUTIC ACTIVE PIPERIDIN DERIVATIVES
NL184420B (en) N-TRIFLUORACETYLADRIAMYCINE DERIVATIVES AND METHOD FOR PREPARING A PHARMACEUTICAL PREPARATION CONTAINING THEY.
BE598470A (en) Laminated product and process for its preparation
NL97706C (en) PROCESS FOR THE PREPARATION OF A NEW PHENOTHIAZINE DERIVATIVE
NL179257C (en) PROCESS FOR PREPARING A MEDICINAL PRODUCT CONTAINING AS 4-PIPERAZINYLPYRIMIDINE DERIVATIVE AS AN ACTIVE COMPOUND AND PROCESS FOR PREPARING ACTIVE COMPOUNDS TO BE USED THEREOF
NL103086C (en) Process for preparing a solution of a polymer in a volatile solvent
NL178077B (en) METHOD FOR PREPARING O-SULPHOBENZOIC ACID IACTAMES AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS.
NL178596B (en) PROCEDURE FOR PREPARING A MEDICINAL PRODUCT WITH ANTIFLOGISTICAL AND / OR ANALGETICAL ACTION AND A PROCESS FOR PREPARING USE AS MEDICINAL COMPOUNDS FOR USE 5-METHYLISOXAZOLE-4-CARBONIC ACID ANILIDE.
NL176460C (en) PROCESS FOR PREPARING RESPECTIVELY MANUFACTURE OF A PHARMACEUTICAL PREPARATION AND PROCEDURE FOR PREPARING USABLE TRIAZOLODIAZEPINE COMPOUNDS THEREIN.
NL171264B (en) PROCESS FOR PREPARING A PHOTOSENSITIVE PREPARATION CONTAINING A PHOTOSENSITIVE PREPARATION CONTAINING AN ALWAYS PREPARED DERIVATIVE OF A SUITABLE LIGHT ALWAYS CONTAINED OF SUCH LIGHT AS A SUFFICIENT LIGHT SOULPHONIC ACID DERIVATIVE.
NL186914B (en) PROCESS FOR PREPARING A GLUCOSE ISOMERASE PRODUCT.
NL179053B (en) N-SUBSTITUTED MORANOLINE DERIVATIVES, METHOD OF PREPARATION THEREOF, AND METHOD OF PREPARATION OF A MEDICINAL PRODUCT CONTAINING SUCH DERIVATIVE.
NL144940B (en) PROCESS FOR PREPARING AN INSECTICIDE PREPARATION CONTAINING AS AN ACTIVE COMPOUND A SUBSTITUTED THENYL ESTER OF A CYCLOPROPANARBON ACID DERIVATIVE AND A PROCESS FOR PREPARING THE ACTIVE COMPOUNDS.
NL930099I1 (en) A process for the preparation of a veterinary medicament or a veterinary nutritional composition and shaped articles thus obtained using cyclopropanecarboxylic acid derivatives as active substance
FR69994E (en) Packaging process for pharmaceutical products
FR68888E (en) Packaging process for pharmaceutical products
FR1150100A (en) Laboratory mixer, especially for pharmaceutical preparations
FR1142278A (en) Fungicidal product
CA551066A (en) Process for forming urea complexes

Legal Events

Date Code Title Description
BC A request for examination has been filed
A85 Still pending on 85-01-01
V1 Lapsed because of non-payment of the annual fee